{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:24:34Z","timestamp":1770243874407,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00393-025-01769-y","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:20:25Z","timestamp":1767885625000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rationale Diagnostik und Differenzialdiagnosen bei IgG4-assoziierten Erkrankungen","Rational diagnostics and differential diagnosis in IgG4-related disease"],"prefix":"10.1007","volume":"85","author":[{"given":"Thea","family":"Thiele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"6","key":"1769_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone\u00a0JH, Zen\u00a0Y, Deshpande\u00a0V (2012) IgG4-related disease. N\u00a0Engl J Med 366(6):539\u2013551. https:\/\/doi.org\/10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"issue":"9976","key":"1769_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa\u00a0T, Zen\u00a0Y, Pillai\u00a0S, Stone\u00a0JH (2015) IgG4-related disease. Lancet 385(9976):1460\u20131471. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0","journal-title":"Lancet"},{"key":"1769_CR3","doi-asserted-by":"publisher","unstructured":"Uchida K, Masamune A, Shimosegawa T, Okazaki K Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009. Int J Rheumatol 2012:358371. https:\/\/doi.org\/10.1155\/2012\/358371","DOI":"10.1155\/2012\/358371"},{"issue":"4","key":"1769_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse\u00a0RC, Stapel\u00a0SO, Schuurman\u00a0J, Rispens\u00a0T (2009) Immunoglobulin G4: an odd antibody. Clin Exp Allergy 39(4):469\u2013477. https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03207.x","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"1769_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino\u00a0CA, Stone\u00a0JH (2020) IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16(12):702\u2013714. https:\/\/doi.org\/10.1038\/s41584-020-0500-7","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1769_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/BOR.0000000000000558","volume":"31","author":"R Kamekura","year":"2019","unstructured":"Kamekura\u00a0R, Takahashi\u00a0H, Ichimiya\u00a0S (2019) New insights into IgG4-related disease: emerging new CD4+ T\u2011cell subsets. Curr Opin Rheumatol 31(1):9\u201315. https:\/\/doi.org\/10.1097\/BOR.0000000000000558","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1769_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10067-022-06339-0","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang\u00a0Y, Zhao\u00a0Z, Gao\u00a0D et\u00a0al (2023) Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease. Clin Rheumatol 42(1):135\u2013143. https:\/\/doi.org\/10.1007\/s10067-022-06339-0","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1769_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00428-024-03757-0","volume":"484","author":"A Czarnywojtek","year":"2024","unstructured":"Czarnywojtek\u00a0A, Agaimy\u00a0A, Pietro\u0144czyk\u00a0K et\u00a0al (2024) IgG4-related disease: an update on pathology and diagnostic criteria with a\u00a0focus on salivary gland manifestations. Virchows Arch 484(3):381\u2013399. https:\/\/doi.org\/10.1007\/s00428-024-03757-0","journal-title":"Virchows Arch"},{"key":"1769_CR9","doi-asserted-by":"publisher","first-page":"787422","DOI":"10.3389\/fimmu.2021.787422","volume":"12","author":"M Maslinska","year":"2022","unstructured":"Maslinska\u00a0M, Dmowska-Chalaba\u00a0J, Jakubaszek\u00a0M (2022) The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol 12:787422","journal-title":"Front Immunol"},{"issue":"1","key":"1769_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","volume":"59","author":"H Goto","year":"2015","unstructured":"Goto\u00a0H, Takahira\u00a0M, Azumi\u00a0A (2015) Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 59(1):1\u20137. https:\/\/doi.org\/10.1007\/s10384-014-0352-2","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"1769_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1755-3768.2012.02526.x","volume":"91","author":"N Andrew","year":"2013","unstructured":"Andrew\u00a0N, Kearney\u00a0D, Selva\u00a0D (2013) IgG4-related orbital disease: a\u00a0meta-analysis and review. acta Ophthalmol 91(8):694\u2013700. https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02526.x","journal-title":"acta Ophthalmol"},{"issue":"12","key":"1769_CR12","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","volume":"98","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa\u00a0T, Egawa\u00a0N, Nakajima\u00a0H (2003) Autoimmune pancreatitis is a\u00a0systemic autoimmune disease. Am J Gastroenterol 98(12):2811\u20132812. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.08758.x","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1769_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/BOR.0b013e3283412f60","volume":"23","author":"K Takuma","year":"2011","unstructured":"Takuma\u00a0K, Kamisawa\u00a0T, Igarashi\u00a0Y (2011) Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 23(1):80\u201387. https:\/\/doi.org\/10.1097\/BOR.0b013e3283412f60","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"1769_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.semdp.2019.07.007","volume":"36","author":"HE Lee","year":"2019","unstructured":"Lee\u00a0HE, Zhang\u00a0L (2019) Immunoglobulin G4-related hepatobiliary disease. Semin Diagn Pathol 36(6):423\u2013433. https:\/\/doi.org\/10.1053\/j.semdp.2019.07.007","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"1769_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jhep.2023.08.005","volume":"79","author":"R Kersten","year":"2023","unstructured":"Kersten\u00a0R, Trampert\u00a0DC, Herta\u00a0T et\u00a0al (2023) IgG4-related cholangitis\u2014a\u00a0mimicker of fibrosing and malignant cholangiopathies. j Hepatol 79(6):1502\u20131523. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.005","journal-title":"j Hepatol"},{"issue":"2","key":"1769_CR16","first-page":"155","volume":"2","author":"A Razok","year":"2023","unstructured":"Razok\u00a0A, Noboa\u00a0RME, Sami\u00a0F, Patolia\u00a0KN, Tanveer\u00a0S (2023) IgG4-related disease and isolated retroperitoneal fibrosis: A\u00a0narrative review. IgG4-related disease and isolated retroperitoneal fibrosis: A\u00a0narrative review. ARP Rheumatol 2(2):155\u2013157","journal-title":"ARP Rheumatol"},{"issue":"11","key":"1769_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/1756-185X.12863","volume":"19","author":"L Lian","year":"2016","unstructured":"Lian\u00a0L, Wang\u00a0C, Tian\u00a0JL (2016) IgG4-related retroperitoneal fibrosis: a\u00a0newly characterized disease. Int J Rheum Dis 19(11):1049\u20131055. https:\/\/doi.org\/10.1111\/1756-185X.12863","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"1769_CR18","doi-asserted-by":"publisher","first-page":"102694","DOI":"10.1016\/j.autrev.2020.102694","volume":"19","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou\u00a0E, Galloway\u00a0J, Fragoulis\u00a0GE (2020) Overview of IgG4-related aortitis and periaortitis. A\u00a0decade since their first description. Autoimmun Rev 19(12):102694. https:\/\/doi.org\/10.1016\/j.autrev.2020.102694","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1769_CR19","doi-asserted-by":"publisher","first-page":"104018","DOI":"10.1016\/j.lpm.2020.104018","volume":"49","author":"C Marvisi","year":"2020","unstructured":"Marvisi\u00a0C, Accorsi Buttini\u00a0E, Vaglio\u00a0A (2020) Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases. presse Med 49(1):104018. https:\/\/doi.org\/10.1016\/j.lpm.2020.104018","journal-title":"presse Med"},{"issue":"3","key":"1769_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cen.13238","volume":"86","author":"MN Stan","year":"2017","unstructured":"Stan\u00a0MN, Sonawane\u00a0V, Sebo\u00a0TJ, Thapa\u00a0P, Bahn\u00a0RS (2017) Riedel\u2019s thyroiditis association with IgG4-related disease. Clin Endocrinol 86(3):425\u2013430. https:\/\/doi.org\/10.1111\/cen.13238","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1769_CR21","doi-asserted-by":"publisher","first-page":"R175","DOI":"10.1530\/EJE-18-1024","volume":"180","author":"M Rotondi","year":"2019","unstructured":"Rotondi\u00a0M, Carbone\u00a0A, Coperchini\u00a0F, Fonte\u00a0R, Chiovato\u00a0L (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180(5):R175\u2013R183. https:\/\/doi.org\/10.1530\/EJE-18-1024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1769_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14397595.2018.1554321","volume":"29","author":"M Kawano","year":"2019","unstructured":"Kawano\u00a0M, Saeki\u00a0T, Nakashima\u00a0H (2019) IgG4-related kidney disease and retroperitoneal fibrosis: An update. Mod Rheumatol 29(2):231\u2013239. https:\/\/doi.org\/10.1080\/14397595.2018.1554321","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1769_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers\u00a0MN, Khosroshahi\u00a0A, Augustin\u00a0T, Deshpande\u00a0V, Stone\u00a0JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204907","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1769_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semarthrit.2019.06.018","volume":"50","author":"J Tang","year":"2020","unstructured":"Tang\u00a0J, Cai\u00a0S, Ye\u00a0C, Dong\u00a0L (2020) Biomarkers in IgG4-related disease: A\u00a0systematic review. Semin Arthritis Rheum 50(2):354\u2013359. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1769_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace\u00a0ZS, Naden\u00a0RP, Chari\u00a0S et\u00a0al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79(1):77\u201387. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216561","journal-title":"Ann Rheum Dis"},{"key":"1769_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/82_2016_39","volume":"401","author":"S Kawa","year":"2017","unstructured":"Kawa\u00a0S (2017) The Immunobiology of Immunoglobulin G4 and Complement Activation Pathways in IgG4-Related Disease. Curr Top Microbiol Immunol 401:61\u201373. https:\/\/doi.org\/10.1007\/82_2016_39","journal-title":"Curr Top Microbiol Immunol"},{"key":"1769_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/art.43269","author":"LYC Chen","year":"2025","unstructured":"Chen\u00a0LYC, Zhang\u00a0L, Fajgenbaum\u00a0DC (2025) Expert Perspective: Diagnosis and Treatment of Castleman Disease. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.43269 (online June\u00a02)","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1769_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMra2102568","volume":"386","author":"D Rossi","year":"2022","unstructured":"Rossi\u00a0D, Bertoni\u00a0F, Marginal-Zone Lymphomas\u00a0ZE (2022) N\u00a0Engl J Med 386(6):568\u2013581. https:\/\/doi.org\/10.1056\/NEJMra2102568","journal-title":"N Engl J Med"},{"issue":"9","key":"1769_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande\u00a0V, Zen\u00a0Y, Chan\u00a0JK et\u00a0al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"issue":"3","key":"1769_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00535-012-0744-3","volume":"48","author":"K Okazaki","year":"2013","unstructured":"Okazaki\u00a0K, Uchida\u00a0K, Ikeura\u00a0T, Takaoka\u00a0M (2013) Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J\u00a0Gastroenterol 48(3):303\u2013314. https:\/\/doi.org\/10.1007\/s00535-012-0744-3","journal-title":"J Gastroenterol"},{"issue":"1","key":"1769_CR31","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2665-9913(24)00192-9","volume":"7","author":"E Della-Torre","year":"2025","unstructured":"Della-Torre\u00a0E, Talarico\u00a0R, Ballarin\u00a0J et\u00a0al (2025) Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework. lancet Rheumatol 7(1):e64\u2013e71. https:\/\/doi.org\/10.1016\/S2665-9913(24)00192-9","journal-title":"lancet Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-025-01769-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:14:24Z","timestamp":1770196464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-025-01769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s00393-025-01769-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"T.\u00a0Thiele\n                      : A.\u00a0Finanzielle Interessen: Anschubfinanzierung\/Verbundf\u00f6rderung der AGJR der DGRh f\u00fcr ein Register zu IgG4-assoziierten Erkrankungen. \u2013\u00a0Referentin: Abbvie, Novartis, Johnson und Johnson, AlfaSigma, Boehringer-Ingelheim, Kostenerstattung: Abbvie, Novartis, Johnson und Johnson, AlfaSigma, Boehringer-Ingelheim, Lilly, UCB.\u00a0\u2013 11\/24 Teilnahme an einem Advisory Board f\u00fcr AlfaSigma . \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Klinik f\u00fcr Rheumatologie und Immunologie Carl-Neuberg-Stra\u00dfe 1, 30625 Hannover | Mitgliedschaft: DGRh.\n                      T.\u00a0Witte\n                      : A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Novartis und Takeda f\u00fcr Verbrauchsmittel bei Forschungsprojekten.\u00a0\u2013 Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: AbbVie, Alexion, AMGEN, AstraZeneca, BMS, Celgene, Celltrion, Chugai, CSL Behring, Fresenius, Galapagos\/Alfasigma, GSK, Janssen, Lilly, Medac, MSD, Novartis, Octapharma, Pfizer, Roche Pharma, Sanofi,Takeda, UCB. \u2013\u00a0Beratungst\u00e4tigkeit f\u00fcr AbbVie, AstraZeneca, GSK, Janssen, Novartis, UCB.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor der Klinik f\u00fcr Rheumatologie und Immunologie, Medizinischen Hochschule Hannover | Mitgliedschaften:DGRh, DGfI.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}